Skip to content

Clinical trials

Terminated Phase 1/2 Head and Neck Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 1/2 Status: Terminated Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20082
20094
20131
20152
20171
20181
20191
20203
20211
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab2
Advaxis, Inc.1
Alentis Therapeutics AG1
Aminex Therapeutics, Inc.1
Atara Biotherapeutics1
Bolt Biotherapeutics, Inc.1
Boneca Corporation1
Bristol-Myers Squibb1
Case Comprehensive Cancer Center1
CytomX Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms23
Squamous Cell Carcinoma of Head and Neck7
Neoplasms6
Neoplasm Metastasis5
Carcinoma, Non-Small-Cell Lung4
Colorectal Neoplasms4
Ovarian Neoplasms4
Breast Neoplasms3
Endometrial Neoplasms3
Lung Neoplasms3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.